← IPO Calendar

Goldline Pharmaceutical IPO IPO

SME12 May 202614 May 2026
Open
12 May 2026
Close
14 May 2026
3
Allotment
Listing
Tue, May 19, 2026
Price Band
₹41 to ₹43
Issue Size
27,00,000 shares (agg. up to ₹12 Cr)
Lot Size
3,000 Shares
Listing Date
Tue, May 19, 2026
Latest GMP
₹15
Est. Gain
34.88%
✦ AI Insight

GMP Trend

19-05-202615Est. ₹58+34.88%
18-05-202615Est. ₹58+34.88%
17-05-202620Est. ₹63+46.51%

Live Subscription

CategorySubscription (times)
Total598.69x

Restated Financials (₹ Cr.)

Period Ended31 Dec 202531 Mar 202531 Mar 202431 Mar 2023
Assets27.4026.2822.9319.39
Total Income21.4128.0623.5719.85
Profit After Tax2.222.831.810.26
EBITDA4.165.834.302.19
NET Worth12.3610.357.865.89
Reserves and Surplus3.651.653.762.08
Total Borrowing9.4711.0311.1310.83
Amount in ₹ Crore

Peer Comparison

CompanyIssue TypeIssue SizeIssue PricePE RatioListing Day CloseListing Gain/Loss %LTP
Speciality Medicines Ltd.SME₹29.14 Cr₹1249.27₹125.90+1.53%₹178.60 (+0.17%)
Accretion Nutraveda Ltd.SME₹24.77 Cr₹12926.27₹191.20+48.22%₹262.00 (-0.70%)
KRM Ayurveda Ltd.SME₹77.49 Cr₹13517.32₹180.70+33.85%₹242.70 (-0.98%)
Curis Lifesciences Ltd.SME₹27.52 Cr₹12812.44₹141.00+10.16%₹105.05 (+2.79%)
Aptus Pharma Ltd.SME₹13.02 Cr₹7011.29₹84.84+21.20%₹249.35 (+2.66%)
Asston Pharmaceuticals Ltd.SME₹27.56 Cr₹12317.83₹124.95+1.59%₹73.50 (-2.00%)
Influx Healthtech Ltd.SME₹58.57 Cr₹9613.04₹126.20+31.46%₹290.00 (-0.60%)
Astonea Labs Ltd.SME₹37.67 Cr₹13527.36₹135.65+0.48%₹283.00 (-1.57%)
Accretion Pharmaceuticals Ltd.SME₹29.75 Cr₹10121.29₹82.95-17.87%₹166.00 (+3.33%)
Sai Parenteral's Ltd.Mainboard₹408.79 Cr₹39272.19₹405.70+3.49%₹570.70 (+1.02%)
Corona Remedies Ltd.Mainboard₹655.37 Cr₹106243.47₹1,438.40+35.44%₹2,064.90 (+0.13%)
Rubicon Research Ltd.Mainboard₹1,377.50 Cr₹48555.75₹628.20+29.53%₹1,419.00 (-3.11%)
Amanta Healthcare Ltd.Mainboard₹126.00 Cr₹12634.59₹141.75+12.50%₹165.27 (-1.98%)
Anlon Healthcare Ltd.Mainboard₹121.03 Cr₹9117.67₹91.73+0.80%₹15.18 (+0.53%)

Objects of the Issue

#Issue ObjectsEst Amt (₹ Cr.)
1Prepayment or repayment of all or a portion of certain outstanding borrowings availed by Company8.35
2General Corporate Purposes1.71
3Issue Expense1.55
Total11.61

About Goldline Pharmaceutical IPO

Goldline Pharmaceuticals is engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” Its product range is divided into five segments: Goldline Pharma: This category includes 42 products to cater to specialties like Physicians, Orthopedics, ENT, Chest Physicians, General and Specialty Surgery, Gastroenterology, Neurology, and Urology. Goldline Cardinal: This category offers 54 products tailored for the Specialty division, serving medical fields such as Physicians, Diabetologists, Endocrinologists, Cardiologists, and General Physicians. Goldline Aayushman: This category comprises 18 products designed for the Specialty division, catering to medical fields such as Pediatricians, Child Specialists, Neonatologists, and General Practitioners. Goldline InLife: This category includes 22 products tailored for the Specialty division, serving Intensivists, Critical Care Consultants, Super Specialty Surgeons, and Physicians. Goldline Wellness: This category includes 10 products tailored Supportive care plays a crucial role in cancer therapy. The company do not manufacture products, it partner with third-party manufacturers who produce the medicines based on

Contact Details

Goldline Pharmaceutical Ltd. Address103, F-1, Leela Apartment, Shilpa HSG SocietyNear Saptagiri Nagar, ShanidhamNarendra NagarNagpur, Maharashtra, 440015+91 712 2786666info@goldlinepharma.inVisit Website